Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3
Public ClinicalTrials.gov record NCT00688246. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Influence of Five Years of Exemestane on Bone Mineral Density in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Learning about the effect of exemestane on bone mineral density in postmenopausal women at increased risk of breast cancer may help plan treatment, decrease the risk of broken bones, and help patients live more comfortably. PURPOSE: This research study is measuring bone mineral density in postmenopausal women at increased risk of developing breast cancer who are receiving exemestane on clinical trial CAN-NCIC-MAP3.
Study identification
- NCT ID
- NCT00688246
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 238 participants
Conditions and interventions
Conditions
Interventions
- biologic sample preservation procedure Other
- dual x-ray absorptometry Procedure
Other · Procedure
Eligibility (public fields only)
- Age range
- 35 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 10, 2008 (Actual)
- Primary completion
- Oct 31, 2011 (Actual)
- Completion
- Jan 10, 2013 (Actual)
- Last update posted
- Aug 4, 2023
2008 – 2013
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Los Angeles Biomedical Research Institute | Torrance | California | 90502 | — |
| The George Washington University | Washington D.C. | District of Columbia | 20037 | — |
| Maine Center for Cancer Medicine and Blood Disorders | Scarborough | Maine | 04074-9308 | — |
| Suburban Hospital Cancer Program | Bethesda | Maryland | 20817 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Hutzel Women's Health Specialists | Detroit | Michigan | 48201 | — |
| University of Medicine and Dentistry of New Jersey | Newark | New Jersey | 07107 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| The Memorial Hospital of Rhode Island | Pawtucket | Rhode Island | 02860 | — |
| Fletcher Allen Health Care | Burlington | Vermont | 05401 | — |
| Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109-1024 | — |
| Univ. of Wisconsin Center for Women's Health and | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00688246, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2023 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00688246 live on ClinicalTrials.gov.